• 1
    Anonymous. The current state of chronic dialysis treatment in Japan (as of December 31, 2000). Ther Aphersis Dial 2003; 7: 335.
  • 2
    Fabrizi F, Poordad FF, Martin P. Hepatitis C infection and the patient with end-stage renal disease. Hepatology 2002; 36: 310.
  • 3
    Tokars JI, Finelli L, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 2001. Semin Dial 2004; 17: 3109.
  • 4
    Petrosillo N, Gilli P, Serraino D, et al. Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis. Am J Kidney Dis 2001; 37: 100410.
  • 5
    Broumand B, Shamshirsaz AA, Kamgar M, et al. Prevalence of hepatitis C infection and its risk factors in hemodialysis patients in Tehran: preliminary report from the ‘effect of dialysis unit isolation on the incidence of hepatitis C in dialysis patients’ project. Saudi J Kidney Dis Transplant 2002; 13: 46772.
  • 6
    Kashem A, Nusarait N, Mohamad M, et al. Hepatitis C virus among hemodialysis patients in Najran: prevalence is more among multi-center visitors. Saudi J Kidney Dis Transplant 2002; 14: 20611.
  • 7
    Jaiswal SK, Chitnis DS, Salgia P, Sepaha A, Pandit CS. Prevalence of hepatitis viruses among chronic renal failure patients on hemodialysis in Central India. Dial Transplant 2002; 31: 23440.
  • 8
    Maisonneuve P, Agodoa L, Gellert R, et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 1999; 354: 939.
  • 9
    Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 2: 6715.
  • 10
    Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002; 36 (Suppl. 1): S3546.
  • 11
    Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH. Hepatitis C and renal disease: an update. Am J Kidney Dis 2002; 42: 63157.
  • 12
    Hanuka N, Sikuler E, Tovbin D, et al. Hepatitis C virus infection in renal failure patients in the absence of anti-hepatitis C virus antibodies. J Viral Hepat 2002; 9: 1415.
  • 13
    Locatelli F, Marcelli D, Conte F, et al. Cardiovascular disease in chronic renal failure: the challenge continues. Nephrol Dial Transplant 2000; 15 (Suppl. 5): S6980.
  • 14
    Poynard T, Conn HO. The retrieval of randomised clinical trials in liver diseases from the medical literature. A comparison of MEDLARS and manual methods. Control Clin Trials 1985; 6: 2719.
  • 15
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 17788.
  • 16
    Stehman-Breen CO, Emerson S, Gretch D, Johnson RJ. Risk of death among chronic dialysis patients infected with hepatitis C virus. Am J Kidney Dis 1998; 32: 62934.
  • 17
    Pereira BJG, Natov SN, Bouthot BA, et al. Effect of hepatitis C infection and renal transplantation in end-stage renal disease. Kidney Int 1998; 53: 137481.
  • 18
    Nakayama E, Akiba T, Marumo F, Sato C. Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol 2000; 11: 1896902.
  • 19
    Espinosa M, Martin-Malo A, Alvarezc de Lara MA, Aljama P. Risk of death and liver cirrhosis in anti-HCV positive long-term haemodialysis patients. Nephrol Dial Transplant 2001; 16: 166974.
  • 20
    DuBois DB, Gretch D, Dela Rosa C, et al. Quantitation of hepatitis C viral RNA in sera of hemodialysis patients: gender-related in viral load. Am J Kidney Dis 1994; 24: 795801.
  • 21
    Cotler SJ, Diaz G, Gundlapalli S, et al. Characteristics of hepatitis C in renal transplant candidates. J Clin Gastroenterol 2002; 35: 1915.
  • 22
    Sterling RK, Sanyal AJ, Luketic VA, et al. Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation. Am J Gastroenterol 1999; 94: 357682.
    Direct Link:
  • 23
    Ghacha R, Sinha AK, Karkar AM. A clinical and histological study in HCV-reactive hemodialysis patients as a pretransplant workup. Dial Transplant 2001; 30: 158.
  • 24
    Martin P, Carter D, Fabrizi F, et al. Histopathological features of hepatitis C in renal transplant candidates. Transplantation 2000; 69: 147984.
  • 25
    Ozdogan M, Ozgur O, Gur G, et al. Histopathological impacts of hepatitis virus infection in hemodialysis patients: should liver biopsy be performed before renal transplantation? Artif Organs 1997; 21: 3558.
  • 26
    Caramelo C, Ortiz A, Aguilera B, et al. Liver disease patterns in hemodialysis patients with antibodies to hepatitis C virus. Am J Kidney Dis 1993; 22: 8228.
  • 27
    Alfurayh O, Sobh M, Buali AR, et al. Hepatitis C virus infection in chronic haemodialysis patients, a clinicopathological study. Nephrol Dial Transplant 1992; 7: 32732.
  • 28
    Pol S, Romeo R, Zins B, et al. Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: significance and therapeutic implications. Kidney Int 1993; 44: 1097100.
  • 29
    Al-Wakeel J, Malik GH, Al-Mohaya S, et al. Liver disease in dialysis patients with antibodies to hepatitis C virus. Nephrol Dial Transplant 1996; 11: 22658.
  • 30
    Glicklich D, Thung SN, Kapoian T, Tellis V, Reinus JF. Comparison of clinical features and liver histology in hepatitis C-positive dialysis patients and renal transplant recipients. Am J Gastroenterol 1999; 94: 15963.
    Direct Link:
  • 31
    Toz H, Ok E, Yzlmaz F, et al. Clinicopathological features of hepatitis C virus infection in dialysis and renal transplantation. J Nephrol 2002; 15: 30812.
  • 32
    Rajkovic IA, Williams R. Abnormalities of neutrophil phagocytosis, intracellular killing, metabolic activity in alcoholic cirrhosis, hepatitis. Hepatology 1986; 6: 25262.
  • 33
    Gomez F, Ruiz P, Schreiber AD. Impaired function of macrophage Fc receptors and bacterial infection in alcoholic cirrhosis. N Engl J Med 1994; 331: 11228.
  • 34
    Hsu CCS, Levy CM. Inhibition of PHA-stimulated lymphocyte transformation by plasma from patients with advanced alcoholic cirrhosis. Clin Exp Immunol 1971; 8: 74960.
  • 35
    Goldblum SE, Reed WP. Host defenses and immunologic alterations associated with chronic hemodialysis. Ann Intern Med 1980; 93: 597613.
  • 36
    Goodkin DA, Bragg-Gresham JL, Koenig KG, et al. Association of comorbid conditions and mortality in haemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcome and Practice Patterns Study (DOOPS). J Am Soc Nephrol 2003; 14: 32707.
  • 37
    Kobayashi M, Tanaka E, Oguchi H, Hora K, Kiyosawa K. Prospective follow-up study of hepatitis C virus infection in patients undergoing maintenance hemodialysis: comparison among haemodialysis units. J Gastroenterol Hepatol 1998; 13: 6049.